INDS Logo   Integrated Nonclinical Development Solutions, Inc.


February's Tox Tuesday's

In case you missed them. An interesting new article finds that Bacterioides fragilis toxin induces a pro-carcinogenic signaling relay from the colonic epithelial cells to a mucosal Th17 response that results in myeloid-cell-dependent distal colon...    »

FDA Clears Oricula Therapeutics Investigational New Drug Application for Clinical Trials

ORC-13661 Could Be the First Medicine Approved Specifically to Prevent Hearing Loss of Patients Using Certain Antibiotics Press Release (PDF)     »

Joyce Zandee of INDS Inc to Speak at Society of Toxicology 56th Annual Meeting

Joyce Zandee, program manager for the INDS Inc. SEND Explorer® development team, will be part of the MPI Research Exhibitor-Hosted Session at the 56th Annual Society of Toxicology Meeting in Baltimore, Maryland. The session is...    »

A New Way to Define Proarrhythmic Risk? Exploring Human Induced Pluripotent Stem-Cell Derived Cardiomyocytes

by Krista K Greenwood, PhD Originally posted on Society of Toxicology’s Communiqué Blog Attrition of novel drug candidates due to cardiovascular liabilities (including proarrhythmic risk due to delayed ventricular repolarization and Torsades-de-Pointes arrhythmia) remains a...    »

Instem to be Exclusive Global Supplier of SEND Explorer®

Instem Expands SEND Suite with Data Visualization and Analysis Solution Instem Signs Agreement with Integrated Nonclinical Development Solutions, Inc.; Becomes Exclusive Global Supplier of SEND Explorer® CONSHOHOCKEN, PA - (BUSINESS WIRE) – July 29, 2016...    »

Integrated Nonclinical Development Solutions, Inc. To Unveil SEND Explorer™ Product Family Version 4.0 at SOT

Society of Toxicology – 55th Annual Meeting and ToxExpo March 13-17, 2016 – New Orleans, LA Booth 753 ToxExpo Hours: Monday, March 14th: 9:15 am – 4:30 pm Tuesday, March 15th: 9:15 am – 4:30...    »

We're Hiring!

Novel and exciting opportunity that is markedly different from a traditional post-doctoral experience. Integrated Nonclinical Development Solutions, Inc. (INDS, Inc.), a drug discovery and development consulting group established in 2007 and located in Ann Arbor,...    »

Tox Tuesday: SEND Explorer to Demo at ACT

The American College of Toxicology Annual Meeting is Nov 8-11th in Las Vegas, NV. Jim, Joyce and Krista will be there representing INDS, Inc. at Booth 319. We will be ready to talk toxicology and...    »

Tox Tuesday - Tech meets Tox: Using Google Glass for tele-toxicology consults

Emergency medicine residents at UMass Medical School wore Glass to evaluate patients while toxicology fellows viewed the interactions remotely. Interestingly, the supervisory toxicology fellows changed their management of the patient after viewing the patient through...    »

INDS launches SEND Explorer Plus

Integrated Nonclinical Development Solutions, Inc. (INDS, Inc.) is pleased to announce the release of SEND Explorer and SEND Explorer Plus 3.0. These validated, web-based applications were designed by scientists to provide advanced viewing, data summarization, and visualization capabilities...    »